- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2009
- Public Summary Document (PSD) July 2009 PBAC Meeting - PDF
Olanzapine pamoate monohydrate – July 2009
Olanzapine pamoate monohydrate, powder for injection with diluent vial, 210 mg, 300 mg and 405 mg, Zyprexa Relprevv®
Last updated
30 October 2009